A. David et al., ANTI-ADENOVIRUS IMMUNE-RESPONSES IN RATS ARE ENHANCED BY INTERLEUKIN-4 BUT NOT INTERLEUKIN-10 PRODUCED BY RECOMBINANT ADENOVIRUS, Human gene therapy, 9(12), 1998, pp. 1755-1768
Citations number
58
Categorie Soggetti
Genetics & Heredity","Biothechnology & Applied Migrobiology","Medicine, Research & Experimental
Recombinant adenoviruses can be used for in vivo gene transfer with gr
eat efficiency. However, the duration of transgene expression and the
possibility of readministering the virus are severely limited by the h
ost anti-adenovirus immune response, which is controlled mainly by cyt
okine networks. Adenoviruses encoding IL-4 (AdIL-4) or IL-10 (AdIL-10)
were administered to rats through the portal vein and the anti-adenov
irus immune response was studied. As compared with administering adeno
viruses without transgene (Addl324) or with the lacZ gene (AdlacZ), Ad
IL-4, but not AdIL-10, resulted in a significant increase in leukocyte
s in the liver, with a predominance of macrophages that peaked on days
7 and 14 after gene transfer and gradually returned to normal by day
28, AdIL-4 induced a significant increase in both neutralizing and ELI
SA-detected anti-adenovirus antibodies, whereas AdIL-10 caused an incr
ease in ELISA-detected antibodies alone. Anti-adenovirus antibodies we
re predominantly of Th1-dependent immunoglobulin subclasses in rats re
ceiving Addl324, AdlacZ, or AdIL-10, whereas animals receiving AdIL-4
showed a predominance of Th2-dependent immunoglobulin subclasses. Type
1 (IFN-gamma) and type 2 (IL-5) cytokines were increased only in live
rs from rats receiving AdIL-4, Rats receiving AdIL-4 showed increased
anti-adenovirus cytotoxic T lymphocyte activity and CD8(+) cell deplet
ion prevented leukocyte infiltration in the liver, These results show
that IL-4 increases local and systemic immune responses against recomb
inant adenoviruses.